Summary

This testimony discusses GAO's findings on differences among the French, United Kingdom, and the United States forces concerning the assessment of Iraqi chemical and biological threats and the use of various countermeasures. GAO also discusses the extent of illness, as well as exposure, reported by each country's veterans, focusing on the results of population-based surveys of Gulf War veterans' exposure to chemicals, as well as drugs and vaccines to guard against warfare agents. This testimony summarized the April 2001 report (GAO-01-13).